| TTM
|
2/28/2026
|
2/28/2025
|
2/29/2024
|
2/28/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
|
-19 | -19 | -142.2600 | -142.2280 | -142.2280 |
|
Gross Profit
|
-19 | -19 | -142.2600 | -142.2280 | -142.2280 |
| Selling, General and Administrative Expenses
|
-804.7730 | -841.2900 | -848.0500 | -788.6410 | -974.0650 |
| Other Income/Expense, Operating
|
-187.9560 | -211.6690 | -100.3590 | -80.7630 | -142.8810 |
|
Operating Income/Expenses
|
-992.7290 | -1,052.9590 | -948.4090 | -869.4040 | -1,116.9460 |
|
Total Operating Profit/Loss
|
-1,011.7290 | -1,071.9590 | -1,090.6690 | -1,011.6320 | -1,259.1740 |
| Total Net Finance Income/Expense
|
39.2930 | 27.4000 | 26.1410 | 36.0700 | -1.1970 |
| Net Investment Income
|
0 | -- | 0 | -2.4510 | -1.3500 |
|
Other Income/Expense, Non-Operating
|
21.6680 | 59.4740 | 114.1040 | 132.0560 | 231.8930 |
|
Non-Operating Income/Expenses, Total
|
60.9610 | 86.8740 | 140.2450 | 165.6750 | 229.3460 |
|
Pretax Income
|
-950.7680 | -985.0850 | -950.4240 | -845.9570 | -1,029.8280 |
|
Net Income from Continuing Operations
|
-950.7680 | -985.0850 | -950.4240 | -845.9570 | -1,029.8280 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-950.7680 | -985.0850 | -950.4240 | -845.9570 | -1,029.8280 |
|
Net Income after Non-Controlling/Minority Interests
|
-950.7690 | -985.0850 | -950.4240 | -845.9570 | -1,029.8280 |
|
Net Income Available to Common Stockholders
|
-950.7690 | -985.0850 | -950.4240 | -845.9570 | -1,029.8280 |
|
Diluted Net Income Available to Common Stockholders
|
-950.7690 | -985.0850 | -950.4240 | -845.9570 | -1,029.8280 |
| Basic EPS
|
0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Diluted EPS
|
0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
|
Basic Weighted Average Shares Outstanding
|
253,989.8930 | 241,494.2190 | 203,661.5510 | 178,736.9350 | 152,613.2730 |
|
Diluted Weighted Average Shares Outstanding
|
253,989.8930 | 241,494.2190 | 203,661.5510 | 178,736.9350 | 152,613.2730 |
|
EBIT
|
-990.0610 | -1,012.4850 | -976.5650 | -882.0270 | -1,028.6310 |
|
EBITDA
|
-971.0610 | -993.4850 | -834.3050 | -739.7990 | -886.4030 |
|
Normalized EBITDA
|
-917.1610 | -923.2010 | -554.7150 | -737.3480 | -637.2380 |
|
Normalized Income
|
-896.8680 | -914.8010 | -670.8340 | -843.5060 | -780.6630 |
|
Total Unusual Items
|
53.9000 | 70.2840 | 279.5900 | 2.4510 | 249.1650 |
|
Total Unusual Items Excluding Goodwill
|
53.9000 | 70.2840 | 279.5900 | 2.4510 | 249.1650 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
2/28/2023 - 8/8/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade